- Investing Ideas
- South Korean Pharmaceuticals & Biotech Mid-Large Cap Stocks
South Korean Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
26
Mid-Large Cap Stocks
26 companies
PharmaResearch
Market Cap: ₩3.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩295,000.00
7D
6.9%
1Y
-29.8%
Yuhan
Market Cap: ₩5.8t
Operates as a pharmaceutical company in South Korea and internationally.
A000100
₩78,300.00
7D
2.1%
1Y
-25.2%
Samsung BiologicsLtd
Market Cap: ₩61.7t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,333,000.00
7D
2.9%
1Y
-14.2%
Hanall Biopharma
Market Cap: ₩2.6t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩52,100.00
7D
-0.2%
1Y
100.8%
Samsung Epis Holdings
Market Cap: ₩11.3t
A biotechnology company, manage the portfolio of biopharmaceutical products.
A0126Z0
₩453,500.00
7D
7.7%
1Y
n/a
D&D Pharmatech
Market Cap: ₩4.0t
Engages in the research and development and manufacturing of pharmaceuticals in South Korea.
A347850
₩91,600.00
7D
2.2%
1Y
169.2%
SK bioscienceLtd
Market Cap: ₩3.1t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩40,000.00
7D
2.6%
1Y
-11.0%
L&C BIOLTD
Market Cap: ₩2.1t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩78,200.00
7D
0.9%
1Y
162.9%
Peptron
Market Cap: ₩5.4t
Engages in the development of peptide-based medicines.
A087010
₩232,500.00
7D
-5.1%
1Y
22.9%
Hanmi Pharm
Market Cap: ₩5.4t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩425,500.00
7D
-0.7%
1Y
46.0%
NatureCellLtd
Market Cap: ₩2.0t
Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.
A007390
₩30,550.00
7D
2.9%
1Y
9.9%
ALTEOGEN
Market Cap: ₩18.9t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩352,500.00
7D
8.0%
1Y
-11.3%
Mezzion PharmaLtd
Market Cap: ₩1.9t
Develops, manufactures, and sells pharmaceutical products in South Korea.
A140410
₩64,100.00
7D
3.4%
1Y
60.5%
Hugel
Market Cap: ₩2.6t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩239,500.00
7D
-1.0%
1Y
-33.4%
Celltrion Pharm
Market Cap: ₩1.9t
A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
A068760
₩44,100.00
7D
3.4%
1Y
-9.5%
ABL Bio
Market Cap: ₩5.5t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩98,700.00
7D
6.8%
1Y
34.8%
SK Biopharmaceuticals
Market Cap: ₩6.9t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩88,700.00
7D
-3.5%
1Y
-2.6%
Celltrion
Market Cap: ₩38.3t
A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.
A068270
₩174,500.00
7D
2.6%
1Y
13.2%
Kolon TissueGene
Market Cap: ₩8.9t
Develops cell therapies for orthopedic diseases and other unmet medical needs.
A950160
₩105,100.00
7D
2.1%
1Y
162.1%
ST PharmLtd
Market Cap: ₩2.6t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩124,100.00
7D
5.1%
1Y
56.9%
Caregen
Market Cap: ₩3.7t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩74,800.00
7D
0.4%
1Y
140.1%
Sam Chun Dang Pharm
Market Cap: ₩6.2t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩265,000.00
7D
9.3%
1Y
60.1%
Aimed Bio
Market Cap: ₩1.8t
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
A0009K0
₩28,600.00
7D
10.9%
1Y
n/a
LigaChem Biosciences
Market Cap: ₩5.1t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩139,700.00
7D
9.1%
1Y
25.6%
OliX Pharmaceuticals
Market Cap: ₩2.6t
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩129,300.00
7D
-1.8%
1Y
176.6%
Voronoi
Market Cap: ₩3.6t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩199,900.00
7D
7.2%
1Y
109.3%